# Contingency Plan Evaluation: Bio-Process Level 3

**Document Reviewed:** `doc/newIntPaper/bioPlanLev-3.md`
**Date:** 2026-02-05
**Evaluator:** Complexity Science Group (AI Agent)

## 1. Executive Summary
The current contingency plans outlined in Section 4 of `bioPlanLev-3.md` are **scientifically sound but operationally immature**. They effectively address the primary *scientific risks* (hypothesis failure and data correlation weakness) with credible alternative research directions. However, they lack the **project management infrastructure** required for a "Level 3" Nature Protocol execution. Crucial elements such as resource reallocation, stakeholder communication, and timeline impact assessments are missing. The plans function more as "Scientific Pivots" than formal "Contingency Plans."

## 2. Detailed Analysis of Existing Measures

### Scenario 4.1: Failure of $D_{v2}$ Universality
*   **Trigger:** "$D_{bio} \approx D_{rand}$ or FR < 2.0"
    *   *Assessment:* **Strong.** The trigger is quantitative, unambiguous, and falsifiable.
*   **Plan:** "Pivot to Hybrid Encoding (70% BDM + 30% Motifs) or focus purely on $\Delta D$ Essentiality... Target Nature Communications."
    *   *Feasibility:* **High.** Reverting to motifs is technically trivial as the code exists (Level 2). Shifting journal targets is a realistic mitigation for reduced novelty.
    *   *Gap:* Does not specify the development time required to implement/tune the "Hybrid Encoding."

### Scenario 4.2: Weak DepMap Correlation
*   **Trigger:** "$\rho(\Delta D, DepMap) < 0.3$"
    *   *Assessment:* **Strong.** A clear statistical threshold derived from standard bioinformatics practices.
*   **Plan:** "Switch from Patient Inference... to Cell Line Specific Networks... Or stratify by Molecular Subtype."
    *   *Feasibility:* **Medium.** Switching to Cell Lines requires a new data ingestion pipeline (CCLE/Achilles data), which is not currently scoped in Phase 2.
    *   *Gap:* This represents a significant scope expansion (new data sources) without a corresponding resource or timeline adjustment.

## 3. Gap Analysis Against Industry Standards

| Criteria | Status | Observation |
| :--- | :--- | :--- |
| **Completeness** | ⚠️ Partial | Covers scientific failure modes but ignores technical (HPC failure), operational (data access loss), and resource (compute budget) risks. |
| **Roles & Responsibilities** | ❌ Missing | No owner assigned for executing the pivot. Who decides to pull the trigger? (Presumably the "Owner," but not explicit). |
| **Communication Protocols** | ❌ Missing | No protocol for notifying stakeholders (e.g., "Project Sponsor") of the downgrade from *Nature* to *Nat. Comms*. |
| **Resource Requirements** | ❌ Missing | No estimate of the computational cost to re-run analysis with "Hybrid Encoding" or download "Cell Line" data. |
| **Timeline Impact** | ❌ Missing | Pivots usually incur delays. The plan implies an instantaneous switch, which is unrealistic. |
| **Testing Procedures** | ❌ Missing | No acceptance criteria defined for the *contingency solution* itself (e.g., "Hybrid Encoding must achieve FR > 5.0"). |

## 4. Recommendations for Improvement

### 4.1 Operationalize the Triggers
*   **Add Decision Authority:** Explicitly state *who* validates the trigger data (e.g., "Lead Data Scientist to confirm $\rho < 0.3$ after 3 independent runs").
*   **Add Time-Box:** Define *when* the trigger is evaluated (e.g., "At the Phase 3/4 Gate Review").

### 4.2 Resource & Timeline Buffers
*   **Recommendation:** Add a "Impact Assessment" field to each contingency.
    *   *Example for 4.2:* "Switching to Cell Lines will require +1 week for data curation and +2000 GPU hours for re-inference."

### 4.3 Expand Risk Coverage
*   **Technical Risk:** Add a plan for HPC outage or memory limits (crucial for N=200,000 nulls).
*   **Data Risk:** Add a plan for "TCGA/DepMap API changes" or "Unavailable Data."

### 4.4 Define "Success" for Contingencies
*   **Recommendation:** Define what "Good" looks like after the pivot.
    *   *Example:* "If pivoting to Hybrid Encoding, target Z-score must exceed 3.0 to proceed."

## 5. Conclusion
The current plan is a **Minimum Viable Contingency** suitable for an agile research team but insufficient for a high-stakes "Nature Protocol" project. To meet industry standards, Section 4 must be expanded to include operational dimensions (Resources, Roles, Timeline) alongside the scientific strategy.
